Cuba tests in Italy the efficacy of its vaccine against COVID-19 Soberana Plus

Cuba is testing in Italy the efficacy of its vaccine against COVID-19 Soberana Plus, intended especially for convalescents of the coronavirus over 19 years old, the state pharmaceutical company BioCubaFarma reported on Tuesday.

“In Europe there is also interest (in Cuban vaccines). For instance, (…), where evaluations are being carried out in convalescent patients with a reinforcement dose of Soberana Plus ”, said at a press conference the president of BioCubaFarma, Eduardo Martínez.

And in those studies “It has been found that (the vaccine) has a strong level of neutralization, both of the Beta strain and the Delta strain”, he pointed.

Soberana Plus, administered in a single dose to convalescents of COVID-19, also after the application of two of Soberana 02, another immunizer developed by the Finlay Institute of Vaccines of Havana.

Cuba has a third immunogen, Abdala, created by the Center for Genetic Engineering and Biotechnology (CIGB).

The vaccines appear to be interested in being evaluated by the WHO as of September 29, the latest update by PAHO of the prequalification process for immunizers before the WHO.

According to this document, all Cuban vaccines are based on a SARS-CoV-2 virus protein, chemically conjugated with meningococcus B, tetanus toxoid or aluminum.

to prevent disease with symptoms, according to its creators.

The green light from the WHO would boost the commercialization of Cuban vaccines, according to BioCubaFarma.

Martínez specified that, in addition to Iran, Vietnam, Nicaragua and Venezuela, countries that have signed contracts with Havana to acquire Cuban vaccines,

“All the vaccines that we are going to produce in the remainder of the year, all are compromised, and we have not wanted to close other agreements, because (…) we want to meet the delivery schedules”, added.

At the close of Monday, Cuba had immunized 55.8% of its 11.2 million inhabitants with its own vaccines, to which it attributes a substantial decrease in infections in recent weeks, after

As of Monday, the island reported 923,966 cases and 7,928 deaths.

Follow us on twitter: